« Back to Record
Russell, J., Vincent, J. L., Kjølbye, A. L., Olsson, H., Blemings, A., Spapen, H. D. M., Carl, P., Laterre, P.-F., & Grundemar, L. (2017). Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Critical care, 21(1), 213. doi:10.1186/s13054-017-1798-7
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/259176



